Sanofi (BIT:1SAN)

Market Cap	111.03B
Revenue (ttm)	44.29B
Net Income (ttm)	5.56B
Shares Out	n/a
EPS (ttm)	4.44
PE Ratio	19.97
Forward PE	n/a
Dividend	3.92 (4.31%)
Ex-Dividend Date	May 12, 2025

Volume	115
Average Volume	752
Open	89.51
Previous Close	90.21
Day's Range	89.50 - 90.03
52-Week Range	85.14 - 111.00
Beta	0.48
RSI	33.17
Earnings Date	Apr 24, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SAN

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.